BLOG.FRANKMS.COM: Category Archive for MS Treatment

CCSVI Warning; FDA

Posted by Frank at 5/10/2012 7:34 PM | Add Comment

Fast Forward LLC,

Posted by Frank at 3/5/2012 12:16 PM | Add Comment

Advances in Using Stem Cells as a Treatment for MS

Posted by Frank at 10/22/2011 4:32 PM | Add Comment

Analysis: Why in an age of health cuts we need more government research

Posted by Frank at 8/4/2011 5:50 PM | Add Comment

Benefit of Disease-Modifying MS Drugs Comes at High Cost

Posted by Frank at 7/22/2011 10:24 PM | Add Comment

CCSVI Death

Posted by Frank at 7/10/2011 2:30 PM | Add Comment

MS Drug Prices

Posted by Frank at 6/11/2011 10:02 AM | Add Comment

Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs

Posted by Frank at 5/22/2011 4:04 PM | Add Comment

Cardiovascular Risks With Oral Fingolimod for Multiple Sclerosis

Posted by Frank at 4/25/2011 8:44 AM | Add Comment

FDA Adds Further Risk Information to Natalizumab Label

Posted by Frank at 4/24/2011 12:58 PM | Add Comment

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial.

Posted by Frank at 4/18/2011 11:14 AM | Add Comment

To repair the damage caused by multiple sclerosis will be possible

Posted by Frank at 4/4/2011 1:22 PM | Add Comment

Early Clinical Trial Results and Observational Study Support Further Research of “Probiotic” Parasitic Worm Treatment Approach in MS

Posted by Frank at 3/19/2011 4:28 PM | Add Comment

Medicare's Policy

Posted by Frank at 1/21/2011 9:31 AM | Add Comment

Stem Cell Seminar

Posted by Frank at 1/12/2011 3:27 PM | Add Comment

Stem Cell Treatment Presentation

Posted by Frank at 1/3/2011 4:27 PM | Add Comment

5 New Cases of PML

Posted by Frank at 11/21/2010 5:03 PM | Add Comment

Potential new Multiple Sclerosis Treatment

Posted by Frank at 11/20/2010 10:57 PM

Novartis’s Multiple Sclerosis Pill Faces FDA Review (Update2)

Posted by Frank at 6/8/2010 11:12 AM | Add Comment

MS Drug Sales

Posted by Frank at 5/27/2010 11:34 AM | Add Comment

Here's an MS Treatment I haven't heard about! Bee sting therapy is so out of date!

Posted by Frank at 5/21/2010 11:02 AM | Add Comment

CCSVI Warning; FDA

Fast Forward LLC,

Advances in Using Stem Cells as a Treatment for MS

Analysis: Why in an age of health cuts we need more government research

Benefit of Disease-Modifying MS Drugs Comes at High Cost

CCSVI Death

MS Drug Prices

Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs

Cardiovascular Risks With Oral Fingolimod for Multiple Sclerosis

FDA Adds Further Risk Information to Natalizumab Label

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial.

To repair the damage caused by multiple sclerosis will be possible

Early Clinical Trial Results and Observational Study Support Further Research of “Probiotic” Parasitic Worm Treatment Approach in MS

Medicare's Policy

Stem Cell Seminar

Stem Cell Treatment Presentation

5 New Cases of PML

Potential new Multiple Sclerosis Treatment

Novartis’s Multiple Sclerosis Pill Faces FDA Review (Update2)

MS Drug Sales

Here's an MS Treatment I haven't heard about! Bee sting therapy is so out of date!

Thousands of MS sufferers could benefit from a revolutionary treatment that injects them with stem cells taken from their own bone marrow.

Amazing Multiple Sclerosis Research for 2010

Possible MS Breakthrough Neglected By American Media

Main Navigation

Back to Main Page

Quick Search

Calendar

Syndicate

Monthly Archives

Category Archives

Recent Posts

Recent Comments

Subscribe